Full Text View
Tabular View
No Study Results Posted
Related Studies
Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature Infants
This study has been terminated.
Study NCT00146497   Information provided by China Medical University Hospital
First Received: September 4, 2005   Last Updated: June 26, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Premature Infants
Respiratory Distress Syndrome
Chronic Lung Disease
Bronchoalveolar Lavage Fluid
Cytokines
Additional conditions recognized in this trial
Lung Diseases
Respiratory Distress Syndrome, Adult
Syndrome
More general conditions related to this trial
Disease
Pathologic Processes
Respiration Disorders
Respiratory Tract Diseases
Interventions listed in this trial
Budesonide-Surfactant
Additional drug interventions recognized in this trial
Budesonide
Pulmonary Surfactants
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
China Medical University Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services